Sina Haftchenary

Sina Haftchenary is a Clinical Development Director in Immuno-oncology at GSK since November 2022, previously holding various positions at Novartis Oncology from October 2016 to November 2022, including Global Scientific Director and Medical Advisor for Solid Tumors. Prior experience includes roles at GSK as a Medical Science Liaison in Respiratory, a two-year stint as a NSERC Postdoctoral Scholar at Harvard University focusing on oncology and drug discovery, and a Ph.D. in Medicinal Chemistry from the University of Toronto with research centered on oncology drug discovery. Leadership skills were honed as President of the Graduate Union at the University of Toronto, managing budgets and organizing significant events, alongside previous roles in communications and strategic planning in various organizations. Educational background includes a Postdoctoral Graduate degree from Harvard University and an Honors Bachelor of Science from York University.